Chemo Pharma Laboratories Ltd.

Chemo Pharma Laboratories Ltd. share price is ₹45.20 as of December 11, 2023, 03:13 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

The 52-week high and low of Chemo Pharma Laboratories Ltd. is ₹46.40 and ₹27.17 respectively as of December 11, 2023, 03:13 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

The PE ratio of Chemo Pharma Laboratories Ltd. is 7.80 as of December 12, 2023.The PE ratio measures the current share price relative to the earnings of the company for past 12 months (as of last reported period).

The trailing twelve month (TTM) PB ratio of Chemo Pharma Laboratories Ltd. is 0.60 as of December 12, 2023. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

The Upper Circuit of Chemo Pharma Laboratories Ltd. is ₹45.2. The Lower Circuit of Chemo Pharma Laboratories Ltd. is ₹40.9.

Chemo Pharma Laboratories Ltd. reported an ROE of 0.40% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Chemo Pharma Laboratories Ltd., Promoter held 27.9%, and the public held 71.8% of the total shares.

You can easily buy shares of Chemo Pharma Laboratories Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

The fair value of Chemo Pharma Laboratories Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.